QURE

$0.00

(

+0.00%

)
Quote details

stock

Uniqure NV

NASDAQ | QURE

14.74

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 18, 2025)

$776.92M

Market Cap

-

P/E Ratio

-3.9

EPS

$19.18

52 Week High

$4.45

52 Week Low

HEALTHCARE

Sector

QURE Chart

Recent Chart
Price Action

QURE Technicals

Tags:

QURE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $8.8M
Total Revenue $27M
Cost Of Revenue $18M
Costof Goods And Services Sold $18M
Operating Income -$184M
Selling General And Administrative $51M
Research And Development $144M
Operating Expenses $196M
Investment Income Net -
Net Interest Income -$42M
Interest Income $21M
Interest Expense $64M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax -$237M
Income Tax Expense $2.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$240M
Comprehensive Income Net Of Tax -
Ebit -$173M
Ebitda -$161M
Net Income -$240M

Revenue & Profitability

Earnings Performance

QURE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $557M
Total Current Assets $390M
Cash And Cash Equivalents At Carrying Value $159M
Cash And Short Term Investments $159M
Inventory $0
Current Net Receivables $5.9M
Total Non Current Assets $166M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $71M
Intangible Assets Excluding Goodwill $71M
Goodwill $22M
Investments -
Long Term Investments $27M
Short Term Investments $209M
Other Current Assets $17M
Other Non Current Assets -
Total Liabilities $563M
Total Current Liabilities $40M
Current Accounts Payable $7.2M
Deferred Revenue -
Current Debt -
Short Term Debt $7.2M
Total Non Current Liabilities $523M
Capital Lease Obligations $15M
Long Term Debt $51M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $66M
Other Current Liabilities $26M
Other Non Current Liabilities $454M
Total Shareholder Equity -$6.8M
Treasury Stock -
Retained Earnings -$1.1B
Common Stock $2.9M
Common Stock Shares Outstanding $49M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$183M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $13M
Capital Expenditures $3.4M
Change In Receivables -
Change In Inventory $2.4M
Profit Loss -
Cashflow From Investment $163M
Cashflow From Financing -$59M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$240M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $8.8M
Total Revenue $27M
Cost Of Revenue $18M
Costof Goods And Services Sold $18M
Operating Income -$184M
Selling General And Administrative $51M
Research And Development $144M
Operating Expenses $196M
Investment Income Net -
Net Interest Income -$42M
Interest Income $21M
Interest Expense $64M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $13M
Income Before Tax -$237M
Income Tax Expense $2.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$240M
Comprehensive Income Net Of Tax -
Ebit -$173M
Ebitda -$161M
Net Income -$240M

QURE News

QURE Profile

Uniqure NV Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

uniQure NV is a pioneering gene therapy company focused on developing innovative treatments for patients with genetic disorders and other severe diseases. Headquartered in Amsterdam, the Netherlands, uniQure leverages its proprietary AAV-based gene therapy platform to address unmet medical needs, aiming to provide long-lasting solutions for conditions such as hemophilia and neurodegenerative diseases. With a robust pipeline of product candidates and a commitment to transforming patient care through advanced genetic treatments, uniQure is positioned as a leader in the evolving field of gene therapy.

ADAP
+108.91%
$0.16
INTC
+23.05%
$30.64
DVLT
+17.15%
$0.40
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
AERT
+63.00%
$0.92
SNAP
+6.32%
$8.49
ATCH
-28.08%
$1.16
GPUS
+23.87%
$0.51
BITF
+4.42%
$3.18
LASE
+69.10%
$4.73
PLUG
+4.86%
$2.09
CDLX
+109.79%
$3.00
RGTI
+12.50%
$24.74
APVO
+38.96%
$1.95
AAL
+0.76%
$12.57
GRAB
+4.09%
$6.35
TSLA
-2.02%
$417.23
SOUN
+3.47%
$15.64
NEHC
-4.00%
$0.45
AMD
-0.81%
$157.85
RAYA
+27.06%
$0.05
ETNB
+85.08%
$14.95
MARA
+7.47%
$18.63
TPIC
-45.91%
$0.12
NIO
-0.65%
$7.40
AXDX
-61.36%
$0.03
YAAS
+14.04%
$0.07
QBTS
+8.31%
$24.41
BMNR
+4.78%
$59.80
PLTR
+4.78%
$176.38
TNMG
-0.27%
$0.32
BINI
-14.33%
$0.05
SOFI
+3.88%
$28.19
CLSK
+16.87%
$13.37
QS
+18.12%
$12.11
DNN
+0.59%
$2.55
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
KDLY
-4.66%
$1.43
TLRY
+5.88%
$1.26
BTG
0.00%
$4.33
RR
+12.81%
$4.49
BBD
-1.05%
$3.27
AAPL
-0.46%
$237.88
IONQ
+1.22%
$66.23
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
QUBT
+4.06%
$18.43
ADD
-25.47%
$0.05
CIFR
-4.28%
$11.85
AMZN
-0.16%
$231.23
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
ACHR
+2.94%
$9.26
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
WBD
+3.44%
$18.60
PFE
+0.35%
$24.13
ABEV
-2.45%
$2.30
RIG
-2.01%
$3.40
IXHL
+2.29%
$0.54
IONZ
-4.37%
$4.59
HIMS
+10.53%
$55.65
NVNI
+13.19%
$0.91
NOK
+1.38%
$4.76
HBAN
+1.88%
$17.87
FAAS
-10.53%
$0.08
ITUB
+1.82%
$7.27
HOOD
+2.24%
$121.29
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
WULF
-1.86%
$11.13
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
MU
+5.56%
$168.89
KEY
+2.16%
$19.11
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
ORIS
+11.11%
$0.15
VALE
-0.32%
$10.84
KVUE
-1.36%
$18.09
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
PBM
+42.47%
$5.30
CAN
+1.23%
$0.81
RIOT
-0.19%
$17.58
BTE
-2.54%
$2.48
RXRX
+4.67%
$4.93
ORCL
-1.59%
$296.60
ADAP
+108.91%
$0.16
INTC
+23.05%
$30.64
DVLT
+17.15%
$0.40
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
AERT
+63.00%
$0.92
SNAP
+6.32%
$8.49
ATCH
-28.08%
$1.16
GPUS
+23.87%
$0.51
BITF
+4.42%
$3.18
LASE
+69.10%
$4.73
PLUG
+4.86%
$2.09
CDLX
+109.79%
$3.00
RGTI
+12.50%
$24.74
APVO
+38.96%
$1.95
AAL
+0.76%
$12.57
GRAB
+4.09%
$6.35
TSLA
-2.02%
$417.23
SOUN
+3.47%
$15.64
NEHC
-4.00%
$0.45
AMD
-0.81%
$157.85
RAYA
+27.06%
$0.05
ETNB
+85.08%
$14.95
MARA
+7.47%
$18.63
TPIC
-45.91%
$0.12
NIO
-0.65%
$7.40
AXDX
-61.36%
$0.03
YAAS
+14.04%
$0.07
QBTS
+8.31%
$24.41
BMNR
+4.78%
$59.80
PLTR
+4.78%
$176.38
TNMG
-0.27%
$0.32
BINI
-14.33%
$0.05
SOFI
+3.88%
$28.19
CLSK
+16.87%
$13.37
QS
+18.12%
$12.11
DNN
+0.59%
$2.55
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
KDLY
-4.66%
$1.43
TLRY
+5.88%
$1.26
BTG
0.00%
$4.33
RR
+12.81%
$4.49
BBD
-1.05%
$3.27
AAPL
-0.46%
$237.88
IONQ
+1.22%
$66.23
MULN
-6.96%
$0.06
VHAI
0.00%
$0.00
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
QUBT
+4.06%
$18.43
ADD
-25.47%
$0.05
CIFR
-4.28%
$11.85
AMZN
-0.16%
$231.23
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
ACHR
+2.94%
$9.26
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
WBD
+3.44%
$18.60
PFE
+0.35%
$24.13
ABEV
-2.45%
$2.30
RIG
-2.01%
$3.40
IXHL
+2.29%
$0.54
IONZ
-4.37%
$4.59
HIMS
+10.53%
$55.65
NVNI
+13.19%
$0.91
NOK
+1.38%
$4.76
HBAN
+1.88%
$17.87
FAAS
-10.53%
$0.08
ITUB
+1.82%
$7.27
HOOD
+2.24%
$121.29
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
WULF
-1.86%
$11.13
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
MU
+5.56%
$168.89
KEY
+2.16%
$19.11
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
ORIS
+11.11%
$0.15
VALE
-0.32%
$10.84
KVUE
-1.36%
$18.09
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
PBM
+42.47%
$5.30
CAN
+1.23%
$0.81
RIOT
-0.19%
$17.58
BTE
-2.54%
$2.48
RXRX
+4.67%
$4.93
ORCL
-1.59%
$296.60

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.